The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to Reach Full Patient Enrollment in the First Half of 2025 Phase III Clinical ...

The battle against breast cancer has produced significant triumphs in recent years, with new and tailored treatments now ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

As with other drugs, venlafaxine can cause side effects, such as sexual problems and weight changes. Venlafaxine comes as an extended-release (ER) oral capsule. It’s available as the brand-name ...